Moolec Science SA (NASDAQ:MLECW – Get Free Report) was the recipient of a significant decline in short interest in January. As of January 30th, there was short interest totaling 4,777 shares, a decline of 74.0% from the January 15th total of 18,390 shares. Based on an average daily trading volume, of 281,351 shares, the short-interest ratio is presently 0.0 days. Based on an average daily trading volume, of 281,351 shares, the short-interest ratio is presently 0.0 days.
Moolec Science Stock Down 16.7%
NASDAQ MLECW traded down $0.00 during trading on Wednesday, reaching $0.01. 7,054 shares of the company traded hands, compared to its average volume of 429,034. The stock’s 50 day moving average price is $0.01 and its two-hundred day moving average price is $0.01. Moolec Science has a 1-year low of $0.00 and a 1-year high of $0.05.
About Moolec Science
Moolec Science is a biotechnology company focused on developing gene-edited livestock as living bioreactors to produce therapeutic proteins. The company leverages CRISPR/Cas9 and related gene-editing technologies to introduce human genes into the genome of pigs, enabling the secretion of complex human proteins in sow’s milk. By combining advanced genetic engineering with traditional livestock breeding, Moolec Science aims to address scalability and cost challenges associated with conventional biologics manufacturing.
The company’s pipeline centers on the production of large multimolecular proteins, including coagulation factors and antibody fragments, for rare diseases and life-threatening conditions.
Read More
- Five stocks we like better than Moolec Science
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Moolec Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moolec Science and related companies with MarketBeat.com's FREE daily email newsletter.
